Table of Contents

 

 

 

 

Preface

ix

 

Acknowledgments

x

1

Introduction

1

SECTION 1

CUTANEOUS NK/T-CELL LYMPHOMAS

9

2

Mycosis Fungoides

11

3

Sézary Syndrome

57

4

Primary Cutaneous CD30+ Lymphoproliferative Disorders

66

 

Lymphomatoid Papulosis

66

 

Cutaneous Anaplastic Large Cell Lymphoma

73

 

“Borderline” Cases

79

5

Subcutaneous “Panniculiti-Like” T-Cell Lymphoma

87

6

Aggressive Cutaneous Cytotoxic Lymphomas

97

 

Primary Cutaneous Aggressive Epidermotropic CD8+ Cytotoxic T-Cell Lymphoma

97

 

Primary Cutaneous γ/δ T-Cell Lymphoma

100

 

Extranodal NK/T-Cell Lymphoma Nasal Type

104

 

Hydroa Vacciniforme-Like Lymphoma

107

7

Cutaneous Adult T-Cell Leukemia/Lymphoma

114

8

Cutaneous Small-Medium Pleomorphic T-Cell Lymphoma

117

9

Other Cutaneous T-Cell Lymphomas

122

 

Primary Cutaneous Peripheral T-Cell Lymphoma, not Otherwise Specified (NOS)

122

 

Angio-Immunoblastic T-Cell Lymphoma

124

SECTION 2

CUTANEOUS B-CELL LYMPHOMAS

127

10

Cutaneous Follicle Center Lymphoma

129

11

Cutaneous Marginal Zone Lymphoma and Variants

141

 

Cutaneous Marginal Zone Lymphoma, Conventional Variant

142

 

Cutaneous Marginal Zone Lymphoma, Lymphoplasmacytic Variant

147

 

Cutaneous Marginal Zone Lymphoma, Plasmacytic Variant

149

12

Cutaneous Diffuse Large B-Cell Lymphoma, Leg Type

156

13

Other Cutaneous B-Cell Lymphomas

164

 

T-Cell/Histiocyte-Rich B-Cell Lymphoma

164

 

Mantle Cell Lymphoma

165

 

Lymphomatoid Granulomatosis

167

 

Cutaneous EBV+ Diffuse Large B-Cell Lymphoma of the Elderly

168

 

Specific Cutaneous Manifestations in Multiple Myeloma

169

SECTION 3

OTHER CUTANEOUS LYMPHOMAS

173

14

Intravascular Large Cell Lymphoma

175

 

Intravascular Large B-Cell Lymphoma

175

 

Intravascular Large NK/T-Cell Lymphoma

178

15

Cutaneous Lymphomas in Immunosuppressed Individuals

182

 

Cutaneous Post-Transplant Lymphoproliferative Disorders

182

 

Cutaneous Lymphomas in HIV-Infected Individuals

185

 

Other Cutaneous Lymphomas Associated with Immune Dysregulation

186

SECTION 4

CUTANEOUS MANIFESTATIONS OF PRECURSOR HEMATOLOGIC NEOPLASMS

189

16

Blastic Plasmacytoid Dendritic Cell Neoplasm (CD4+/CD56+Hematodermic Neoplasm)

191

17

Cutaneous Lymphoblastic Lymphomas

199

 

Cutaneous B-Lymphoblastic Lymphoma

199

 

Cutaneous T-Lymphoblastic Lymphoma

202

SECTION 5

SPECIFIC CUTANEOUS MANIFESTATIONS OF LEUKEMIAS

205

18

Cutaneous Manifestations of B-Cell Chronic Lymphocytic Leukemia

207

19

Cutaneous Manifestations of Myelogenous Leukemia

212

20

Cutaneous Manifestations of Other Leukemias

219

 

T-Cell Prolymphocytic Leukemia

219

 

Aggressive Natural Killer Cell Leukemia

220

SECTION 6

CUTANEOUS MANIFESTATIONS OF HODGKIN LYMPHOMA

223

21

Cutaneous Manifestations of Hodgkin Lymphoma

225

SECTION 7

PSEUDOLYMPHOMAS OF THE SKIN

229

22

Pseudolymphomas of the Skin

231

SECTION 8

THE CUTANEOUS “ATYPICAL LYMPHOID PROLIFERATION”

263

23

The Cutaneous “Atypical Lymphoid Proliferation”

265

 

Index

267